Resultados da busca - Mark T.A. Donoghue
- Mostrando 1 - 20 resultados de 45
- Ir para a próxima página
-
1
-
2
Discovery through clinical sequencing in oncology por Mark T.A. Donoghue, Alison M. Schram, David M. Hyman, Barry S. Taylor
Publicado em 2020Revisão -
3
Molecular Changes in Retinoblastoma beyond RB1: Findings from Next-Generation Sequencing por Jasmine H. Francis, Allison L. Richards, Diana Mandelker, Michael F. Berger, Michael F. Walsh, Ira J. Dunkel, Mark T.A. Donoghue, David H. Abramson
Publicado em 2021Artigo -
4
MicroRNA-9 Inhibition of Cell Proliferation and Identification of Novel miR-9 Targets by Transcriptome Profiling in Breast Cancer Cells por S. Duygu Selçuklu, Mark T.A. Donoghue, Kristina Rehmet, Matheus de Souza Gomes, Antoine Fort, Prasad Kovvuru, Mohan Kumar Muniyappa, Michael J. Kerin, Anton J. Enright, Charles Spillane
Publicado em 2012Artigo -
5
Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes por Yasser Ged, Ying‐Bei Chen, Andrea Knežević, Mark T.A. Donoghue, Maria I. Carlo, Chung‐Han Lee, Darren R. Feldman, Sujata Patil, A. Ari Hakimi, Paul Russo, Martin H. Voss, Robert J. Motzer
Publicado em 2019Artigo -
6
Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing por Martee L. Hensley, Shweta S. Chavan, David B. Solit, Rajmohan Murali, Robert A. Soslow, Sarah Chiang, Achim A. Jungbluth, Chaitanya Bandlamudi, Preethi Srinivasan, William D. Tap, Evan Rosenbaum, Barry S. Taylor, Mark T.A. Donoghue, David M. Hyman
Publicado em 2020Artigo -
7
Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group por D. Mandelker, Mark T.A. Donoghue, Sabrina Talukdar, Chaitanya Bandlamudi, Preethi Srinivasan, Malavika Vivek, S. Jezdic, Helen Hanson, Katie Snape, A. Kulkarni, Lara Hawkes, J.-Y. Douillard, S.E. Wallace, Emmanuelle Rial‐Sebbag, F. Meric-Bersntam, Angela George, Daniel Chubb, Chey Loveday, Marc Ladanyi, MF Berger, B.S. Taylor, Clare Turnbull
Publicado em 2019Artigo -
8
Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas por A.J. Schoenfeld, H. Rizvi, Chai Bandlamudi, Jennifer L. Sauter, William D. Travis, Natasha Rekhtman, Andrew J. Plodkowski, Rocío Pérez-Johnston, Peter Sawan, Amanda Beras, Jacklynn V. Egger, M. Ladanyi, Kathryn C. Arbour, Charles M. Rudin, G.J. Riely, Barry S. Taylor, Mark T.A. Donoghue, Matthew D. Hellmann
Publicado em 2020Artigo -
9
Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer por Corrin A. Wohlhieter, Allison L. Richards, Fathema Uddin, Christopher H. Hulton, Álvaro Quintanal-Villalonga, Axel Martin, Elisa de Stanchina, Umesh Bhanot, Marina Asher, Nisargbhai Shah, Omar Hayatt, Darren J. Buonocore, Natasha Rekhtman, Ronglai Shen, Kathryn C. Arbour, Mark T.A. Donoghue, John T. Poirier, Triparna Sen, Charles M. Rudin
Publicado em 2020Artigo -
10
Genome sequencing of the extinct Eurasian wild aurochs, Bos primigenius, illuminates the phylogeography and evolution of cattle por Stephen D. E. Park, David A. Magee, Paul McGettigan, Matthew D. Teasdale, Ceiridwen J. Edwards, Amanda J. Lohan, Alison Murphy, Martin Braud, Mark T.A. Donoghue, Yuan Liu, Andrew Chamberlain, Kévin Rue-Albrecht, Steven Schroeder, Charles Spillane, Shuaishuai Tai, Daniel G. Bradley, Tad S. Sonstegard, Brendan Loftus, David E. MacHugh
Publicado em 2015Artigo -
11
Genome doubling shapes the evolution and prognosis of advanced cancers por Craig M. Bielski, Ahmet Zehir, Alexander Penson, Mark T.A. Donoghue, Walid K. Chatila, Joshua Armenia, Matthew T. Chang, Alison M. Schram, Philip Jonsson, Chaitanya Bandlamudi, Pedram Razavi, Gopa Iyer, Mark E. Robson, Zsofia K. Stadler, Nikolaus Schultz, José Baselga, David B. Solit, David M. Hyman, Michael F. Berger, Barry S. Taylor
Publicado em 2018Artigo -
12
Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer por Craig M. Bielski, Mark T.A. Donoghue, Mayur Gadiya, Aphrothiti J. Hanrahan, Helen Won, Matthew T. Chang, Philip Jonsson, Alexander Penson, Alexander N. Gorelick, Christopher Harris, Alison M. Schram, Aijazuddin Syed, Ahmet Zehir, Paul B. Chapman, David M. Hyman, David B. Solit, Kevin Shannon, Sarat Chandarlapaty, Michael F. Berger, Barry S. Taylor
Publicado em 2018Artigo -
13
Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy por Charlotte S. Walmsley, Philip Jonsson, Michael L. Cheng, Sean M. McBride, Christopher Kaeser, H. Alberto Vargas, Vincent P. Laudone, Barry S. Taylor, Rajya Kappagantula, Priscilla Baez, Allison L. Richards, Anne Marie Noronha, D. S. Perera, Michael F. Berger, David B. Solit, Christine A. Iacobuzio‐Donahue, Howard I. Scher, Mark T.A. Donoghue, Wassim Abida, Alison M. Schram
Publicado em 2024Artigo -
14
Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch Syndrome por Timothy F. Donahue, Aditya Bagrodia, François Audenet, Mark T.A. Donoghue, K. Eugene, John P. Sfakianos, Dahlia Sperling, Hikmat Al‐Ahmadie, Mark Clendenning, Christophe Rosty, Daniel D. Buchanan, Mark A. Jenkins, John L. Hopper, Ingrid Winship, Allyson Templeton, Michael F. Walsh, Zsofia K. Stadler, Gopa Iyer, Barry S. Taylor, Jonathan Coleman, Noralane M. Lindor, David B. Solit, Bernard H. Bochner
Publicado em 2018Artigo -
15
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma por François Audenet, Sumit Isharwal, K. Eugene, Mark T.A. Donoghue, Esther Drill, Irina Ostrovnaya, Eugene J. Pietzak, John P. Sfakianos, Aditya Bagrodia, Paari Murugan, Guido Dalbagni, Timothy F. Donahue, Jonathan E. Rosenberg, Dean F. Bajorin, Maria E. Arcila, Jaclyn F. Hechtman, Michael F. Berger, Barry S. Taylor, Hikmat Al‐Ahmadie, Gopa Iyer, Bernard H. Bochner, Jonathan Coleman, David B. Solit
Publicado em 2018Artigo -
16
The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung Cancer por Adam J. Schoenfeld, Chai Bandlamudi, Jessica A. Lavery, Joseph Montecalvo, Azadeh Namakydoust, Hira Rizvi, Jacklynn V. Egger, Carla P. Concepcion, Sonal Paul, Maria E. Arcila, Yahya Daneshbod, Jason C. Chang, Jennifer L. Sauter, Amanda Beras, Marc Ladanyi, Tyler Jacks, Charles M. Rudin, Barry S. Taylor, Mark T.A. Donoghue, Glenn Heller, Matthew D. Hellmann, Natasha Rekhtman, Gregory J. Riely
Publicado em 2020Artigo -
17
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center por Evan Rosenbaum, Cristina R. Antonescu, Shaleigh Smith, Martina Bradić, Daniel Kashani, Allison L. Richards, Mark T.A. Donoghue, Ciara M. Kelly, Benjamin A. Nacev, Jason E. Chan, Ping Chi, Mark A. Dickson, Mary Lou Keohan, Mrinal M. Gounder, Sujana Movva, Viswatej Avutu, Katherine A. Thornton, Ahmet Zehir, Anita S. Bowman, Samuel Singer, William D. Tap, Sandra P. D’Angelo
Publicado em 2022Artigo -
18
Avelumab Plus Talazoparib in Patients With <i>BRCA1/2</i>- or <i>ATM</i>-Altered Advanced Solid Tumors por Alison M. Schram, Nicoletta Colombo, Edward Arrowsmith, Vivek Narayan, Kan Yonemori, Giovanni Scambia, Amelia Zelnak, Todd M. Bauer, Ning Jin, Susanna V. Ulahannan, Marco Colleoni, Philippe Aftimos, Mark T.A. Donoghue, Ezra Rosen, Vasilisa A. Rudneva, Melinda L. Telli, Susan M. Domchek, Matthew D. Galsky, Margaret Hoyle, Colombe Chappey, Ross Stewart, John A. Blake-Haskins, Timothy A. Yap
Publicado em 2022Artigo -
19
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma por Caitlin A. McIntyre, Sharon Lawrence, Allison L. Richards, Joanne F. Chou, Winston Wong, Marinela Capanu, Michael F. Berger, Mark T.A. Donoghue, Kenneth H. Yu, Anna M. Varghese, David P. Kelsen, Wungki Park, Vinod P. Balachandran, T. Peter Kingham, Michael I. D’Angelica, Jeffrey A. Drebin, William R. Jarnagin, Christine A. Iacobuzio‐Donahue, Peter J. Allen, Eileen M. O’Reilly
Publicado em 2020Artigo -
20
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer por Timothy N. Clinton, Ziyu Chen, Hannah Wise, Andrew T. Lenis, Shweta S. Chavan, Mark T.A. Donoghue, Nima Almassi, Carissa Chu, Shawn Dason, Pavitra Rao, James A. Rodrigues, Naresh Vasani, Fourat Ridouani, Jonathan E. Rosenberg, Dean F. Bajorin, Min Yuen Teo, Bernard H. Bochner, Michael F. Berger, Irina Ostrovnaya, Eugene J. Pietzak, Gopa Iyer, Sizhi Paul Gao, Wenhuo Hu, Hikmat Al‐Ahmadie, David B. Solit
Publicado em 2022Artigo
Ferramentas de busca:
Assuntos relacionados
Biology
Cancer
Genetics
Medicine
Gene
Internal medicine
Oncology
Cancer research
Mutation
Pathology
Breast cancer
Computational biology
Allele
Colorectal cancer
KRAS
Carcinogenesis
Germline mutation
Lung cancer
Adenocarcinoma
Germline
Immunotherapy
Lung
Metastasis
Somatic cell
Somatic evolution in cancer
Clinical trial
Cohort
DNA
DNA damage
Gastroenterology